Company: PCRX
Filing Date: 2025-02-27
Form Type: S-8
Source: 0001396814-25-000043
Chunk: 3

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: S-8
Chunk 3
---
 107         |     | Filing Fee Table.                                                                                                                                                                        |

### SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tampa, State of Florida, on February 27, 2025.

| PACIRA BIOSCIENCES, INC.             |
| /s/ Frank D. Lee                     |
| Frank D. Lee                         
 Chief Executive Officer and Director |

### POWER OF ATTORNEY
Each person whose individual signature appears below hereby authorizes Frank D. Lee, Shawn M. Cross and Kristen Williams, or any of them, as attorneys-in-fact, with full power of substitution, to execute in the name and on the behalf of each person, individually and in each capacity stated below, and to file, any and all amendments to this registration statement, including any and all post-effective amendments.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated and on February 27, 2025.

| Principal Executive Officer          |     | Directors                   |     |                                 |
| /s/ FRANK D. LEE                     |     | /s/ MARCELO BIGAL           |     | /s/ ABRAHAM CEESAY              |
| Frank D. Lee                         |     | Marcelo Bigal               |     | Abraham Ceesay                  |
| Chief Executive Officer and Director |     |                             |     |                                 |
|                                      |     | /s/ CHRISTOPHER J. CHRISTIE |     | /s/ MARK FROIMSON               |
| Principal Financial Officer          |     | Christopher J. Christie     |     | Mark Froimson                   |
| /s/ SHAWN M. CROSS                   |     | /s/ MARK KRONENFELD         |     | /s/ MICHAEL YANG                |
| Shawn M. Cross                       |     | Mark Kronenfeld             |     | Michael Yang                    |
| Chief Financial Officer              |     |                             |     |                                 |
|                                      |     | /s/ ALETHIA YOUNG           |     | /s/ LAURA BREGE                 |
| Principal